CoChat

Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome

Open access
Khani, Behnaz, Mardanian, Farahnaz, Fesharaki, Sajadeh Jafari · 2017 · Journal of Research in Medical Sciences
Cited by 59

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background: Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder with unknown etiology and with different complications. The aim of this study was to evaluate the effect of omega-3 supplementation on PCOS symptoms and metabolic syndrome. Materials and Methods: This double-blind clinical trial was performed in 2015 in Alzahra and Shahid Beheshti Hospitals, Isfahan, Iran, on 88 patients with PCOS. Intervention group took omega-3 supplements with dose of 2 g/day for 6 months (two capsules), but control group received two olive oil capsules. Finally, ultrasound and laboratory findings and the recovery rate of menstrual disorders in both groups were compared. Results: After 6 months’ intervention, waist circumference (WC) was significantly lower in omega-3 as compared to control (81.18 ± 2.87 vs. 84.22 ± 2.61 cm, respectively, P < 0.0001). High-density lipoprotein was increased (47.2 ± 1.37 vs. 41.56 ± 1.34 mg/dl, respectively, P < 0.0001) while low-density lipoprotein (107.79 ± 1.68 vs. 117.4 ± 1.57 mg/dl, respectively), triglyceride (116.02 ± 3.13 vs. 125.06 ± 2.91 mg/dl, respectively), and cholesterol (180.34 ± 6.34 vs. 189.56 ± 5.93 mg/dl, respectively) in omega-3 were significantly lower than control (P < 0.0001). The interval between periods in omega-3 was significantly shorter than control (29.83 ± 4.68 vs. 47.11 ± 8.72 days, respectively, P < 0.001). Conclusion: Omega-3 decrease lipid profiles, WC, and interval between periods while weight, hip circumference, fasting blood sugar, number of ovarian follicle, size of ovary, bleeding volume, menstrual bleeding, and hirsutism score did not change by administration of omega-3.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/jrms.jrms_644_16

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 21

  1. Baptiste, 2010, Insulin and hyperandrogenism in women with polycystic ovary syndrome, J Steroid Biochem Mol Biol, 122, 42, 10.1016/j.jsbmb.2009.12.010 · DOI · Paper page
  2. Kelley, 2014, Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome, stroenterol, 20, 14172
  3. González, 2013, Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome, Am J Physiol Endocrinol Metab, 304, E375, 10.1152/ajpendo.00491.2012 · DOI · Paper page
  4. Khani, 2011, Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome, J Res Med Sci, 16, 297
  5. Mehrabian, 2011, The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria, Endokrynol Pol, 62, 238
  6. Chittenden, 2009, Polycystic ovary syndrome and the risk of gynaecological cancer: A systematic review, Reprod Biomed Online, 19, 398, 10.1016/S1472-6483(10)60175-7 · DOI · Paper page
  7. Haji Shafiha, 2007, Investigating validity criteria of vaginal ultrasound (ovarian volume, the ovarian stroma and the stromal surface of the ovary) in the diagnosis of polycystic ovary syndrome, Urmia Med J, 3, 538
  8. Glueck, 2003, Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome, Metabolism, 52, 908, 10.1016/S0026-0495(03)00104-5 · DOI · Paper page
  9. Lo, 2006, Epidemiology And Adverse Cardiovascular Risk Profile Of Diagnosed Polycystic Ovary Syndrome, J Clin Endocrinol Metab, 91, 1357, 10.1210/jc.2005-2430 · DOI · Paper page
  10. Phelan, 2011, Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: Results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial, Am J Clin Nutr, 93, 652, 10.3945/ajcn.110.005538 · DOI · Paper page
  11. Rafraf, 2012, Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome, J Am Coll Nutr, 31, 361, 10.1080/07315724.2012.10720443 · DOI · Paper page
  12. Hurst, 2004, Effects of n-3 polyunsaturated fatty acids on COX-2 and PGE2 protein levels in articular cartilage chondrocytes, Int J Exp Pathol, 85, A22, 10.1111/j.0959-9673.2004.369ab.x · DOI
  13. Davidson, 2006, Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids, Am J Cardiol, 98, 27i, 10.1016/j.amjcard.2005.12.024 · DOI · Paper page
  14. Nestel, 2000, Fish oil and cardiovascular disease: Lipids and arterial function, Am J Clin Nutr, 71, 228S, 10.1093/ajcn/71.1.228S · DOI · Paper page
  15. Cussons, 2009, Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: A randomized controlled trial employing proton magnetic resonance spectroscopy, J Clin Endocrinol Metab, 94, 3842, 10.1210/jc.2009-0870 · DOI · Paper page
  16. Sadeghi, 2016, Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials, Diabetes Metab Syndr
  17. Mohammadi, 2012, Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome, Asia Pac J Clin Nutr, 21, 511
  18. Azziz, 2005, Diagnostic criteria for polycystic ovary syndrome: A reappraisal, Fertil Steril, 83, 1343, 10.1016/j.fertnstert.2005.01.085 · DOI · Paper page
  19. Vargas, 2011, Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome, Metabolism, 60, 1711, 10.1016/j.metabol.2011.04.007 · DOI · Paper page
  20. Hajianfar, 2011, The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes, J Res Med Sci, 16, 490
  21. Nadjarzadeh, 2013, The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial, Iran J Reprod Med, 11, 665

Cited by

See all 59

Metadata

Authors
Khani, B., Mardanian, F., & Fesharaki, S. J.
Venue
Journal of Research in Medical Sciences
Published
2017-01
Volume
22
Issue
1
Pages
64-64
ISSN
  • 1735-1995 (ISSN-L)
  • 1735-7136
OpenAlex
W2610335779
Cited by
59
References
3
FWCI
4.32
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. https://app.cochat.ai/papers/10.4103/jrms.jrms_644_16
The paper
Khani, B., Mardanian, F., & Fesharaki, S. J. (2017). Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. Journal of Research in Medical Sciences. https://doi.org/10.4103/jrms.jrms_644_16

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.